Molecular Iodine as a New Frontline Defense Against COVID19 in the Dental Practice


Wednesday, December 9, 2020


05:00 PM America/Los_Angeles

Convert to my timezone
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
Required fields
If you have already registered and can't locate your registration confirmation email,click here!
The email address is incorrect. Please double-check your email address.

A confirmation email with logging details has been sent to the provided email.

System configuration test. Click here!

A message from Dr. Herb Moskowitz, DDS:


TITLE: Molecular Iodine as a New Frontline Defense Against COVID19 in the Dental Practice. An Analysis of Antimicrobial Technologies in Dental Practices to Advance Safety and Efficacy During a Pandemic. 

"There is overwhelming evidence backed by research that the COVID-19 virus can be safely and effectively inactivated by molecular iodine, the biocidal component of povidone-iodine." D. Scott Trettenero, DDS. November 16, 2020 DentistryIQ

1 CEU: Live Interactive Webinar | AGD PACE

AGD Subject Code: 010 Basic Sciences. Pharmacotherapeutics, Emerging Technology

*If you cannot attend:  A link to the recording will be emailed following the event.

COST: No charge

SPONSOR:  ioTech International

PRESENTER: Dr. Herb Moskowitz

DESCRIPTION: A new generation of super-iodines is being developed with proven anti-virucidal activity against SARS-CoV-2. This course will analyze the efficacy and safety of current anti-microbial rinses and introduce the latest generation of rinses under development. Upon the completion of this webinar, you will be provided with evidence-based studies showing the most effective rinses to protect both patients and staff.


  1. Review the evolution of iodine in becoming a standard of care.
  2. Learn about a technological breakthrough leading to a new class of "super" iodines.
  3. Compare the efficacy of commonly used oral rinses against SARS-CoV-2
  4. Understand how the implementation of the new "super" iodines in your practice will benefit your patients.
  5. Compare the advantages and disadvantages of commonly used oral rinses.
  6. Describe the misconceptions related to iodine sensitivity.
  7. Compare current trends in anti-microbial technologies and describe their efficacy and effectiveness. 
  8. Learn why periodontal bacteremias are now considered a cause of cardiovascular disease. 
HOSTED BY:Dental CE Academy #1 Trusted Resource created by a public health dentist. Showcasing Excellence in Dental Education and Innovation to Improve Patient Outcomes.
Disclosure: Dr. Herb Moskowitz, DDS is the Chairman of ioTech International, and has a financial interest and paid speaker.

    Dr. Herb Moskowitz

    Dr. Herb Moskowitz is the Chairman and Co-Founder of ioTech International. He is the co-author of ioTech's U.S. patent and global patent applications. He previously founded and served as Chairman and CEO of Advanced Tissue Sciences and Life Medical Sciences, two publicly traded medical technology companies. He has also practiced clinical dentistry for more than 25 years and is a graduate of the University of Tennessee Dental School.
    The views expressed and opinions and materials presented during these presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy. Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based upon the speakers' own clinical experience and should not be construed as Dental CE Academy recommended. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to new interest and scientific breakthroughs in dentistry.